ER+, HER 2- Breast Cancer
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| IDE574 | IDEAYA Biosciences, Inc. (IDYA) |
Frequently asked questions
How many drugs are in development for ER+, HER 2- Breast Cancer?
BioSniper tracks 1 drug in development for ER+, HER 2- Breast Cancer across 1 company.
How many clinical trials target ER+, HER 2- Breast Cancer?
There are 1 clinical trial targeting ER+, HER 2- Breast Cancer tracked by BioSniper.
Deep-dive into ER+, HER 2- Breast Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis